Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in society as a whole and industries around the world, including many areas of...
Ablation Systems
This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems.
-
-
Clifford Robinson, M.D., associate professor of radiation oncology, chief of the SBRT service, director of...
-
Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director...
-
Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how...
Peter_Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.
Feature | EP Lab | December 23, 2019 | J. Peter Weiss, M.D., MSc
Robotic technology, which helps...
Videos | Ablation Systems | September 26, 2019
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can...
The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.
News | EP Mapping and Imaging Systems | August 19, 2019
August 19, 2019 — Scientists at Johns Hopkins have successfully created...
Videos | EP Lab | July 26, 2019
Videos | EP Lab | July 25, 2019
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.
Feature | Atrial Fibrillation | July 24, 2019
July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications...
News | EP Mapping and Imaging Systems | July 15, 2019
July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in...
Technology | EP Mapping and Imaging Systems | July 01, 2019
July 1, 2019 — Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its...
News | Left Atrial Appendage (LAA) Occluders | June 12, 2019
June 12, 2019 — Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the...
Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.
News | EP Mapping and Imaging Systems | May 28, 2019
May 28, 2019 — Researchers have developed the first algorithm that can locate patient-specific...
Acutus Medical's acquisition of Rhythm Xience brings the Flextra steerable introducer sheath into Acutus Medical's product portfolio.
News | EP Mapping and Imaging Systems | May 17, 2019
May 17, 2019 — At the 40th annual Heart Rhythm...
Technology | Analytics Software | May 16, 2019
May 16, 2019 — Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s...
News | Ablation Systems | May 16, 2019
May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro...
News | Ablation Systems | May 16, 2019
May 16, 2019 — CardioFocus Inc. announced the presentation of results from its...
